Skip to main content
Fig. 1 | Advances in Rheumatology

Fig. 1

From: Predictors of response to etanercept-methotrexate treatment: a post hoc logistic regression analysis of a randomized, open-label study in Latin American patients with rheumatoid arthritis

Fig. 1

Baseline Factors Associated with Response to ETN + MTX at Weeks 24 (A) and 128* (B). *Results from one-way ANOVA models and in chi-square tests. ANOVA analysis of variance, BMI body mass index, CRP C-reactive protein, DAS28 Disease Activity Score in 28 joints, ESR erythrocyte sedimentation rate, ETN etanercept, SF-36 36-Item Short Form Survey, HAQ Health Assessment Questionnaire, MTX methotrexate, VAS visual analog scale

Back to article page

Advances in Rheumatology

ISSN: 2523-3106